Immix Biopharma Inc (IMMX)
1.56
-0.03
(-1.89%)
USD |
NASDAQ |
Sep 27, 16:00
1.50
-0.06
(-3.85%)
After-Hours: 20:00
Immix Biopharma Total Assets (Quarterly): 28.84M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 28.84M |
| March 31, 2024 | 34.35M |
| December 31, 2023 | 19.93M |
| September 30, 2023 | 22.47M |
| June 30, 2023 | 15.57M |
| March 31, 2023 | 13.21M |
| December 31, 2022 | 14.91M |
| Date | Value |
|---|---|
| September 30, 2022 | 17.40M |
| June 30, 2022 | 19.09M |
| March 31, 2022 | 20.02M |
| December 31, 2021 | 18.19M |
| September 30, 2021 | 0.4953M |
| June 30, 2021 | 0.3516M |
| December 31, 2020 | 0.5396M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.3516M
Minimum
Jun 2021
34.35M
Maximum
Mar 2024
16.10M
Average
17.79M
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Protalix BioTherapeutics Inc | 91.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.945M |
| Shareholders Equity (Quarterly) | 23.89M |